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Background: Good bone and joint health is essential for the physical tasks of daily living and poorer indicators
of physical capability in older adults have been associated with increased mortality rates. Genetic variants of
indicators of bone and joint health may be associated with measures of physical capability.
Methods: As part of the Healthy Ageing across the Life Course (HALCyon) programme, men and women aged
between 52 and 90+ years from six UK cohorts were genotyped for a polymorphism associated with serum
calcium (rs1801725, CASR), two polymorphisms associated with bone mineral density (BMD) (rs2941740,
ESR1 and rs9594759, RANKL) and one associated with osteoarthritis risk rs3815148 (COG5). Meta-analysis
was used to pool within-study effects of the associations between each of the polymorphisms and measures
of physical capability: grip strength, timed walk or get up and go, chair rises and standing balance.
Results: Few important associations were observed among the several tests. We found that carriers of the
serum calcium-raising allele had poorer grip strength compared with non-carriers (pooled p=0.05, n=
11,239) after adjusting for age and sex. Inconsistent results were observed for the two variants associated
with BMD and we found no evidence for an association between rs3815148 (COG5) and any of the physical
capability measures.
Conclusion: Our ﬁndings suggest elevated serum calcium levels may lead to lower grip strength, though this
requires further replication. Our results do not provide evidence for a substantial inﬂuence of these variants
in ESR1, RANKL and COG5 on physical capability in older adults.© 2012 Elsevier Inc. Open access under CC BY license.steoarthritis; BMI, body mass
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 license.Introduction
Bones have several important functions, including, providing sup-
port, permitting movement and storing minerals [1]. The indicators of
poorer bone health observed in later life have been associated with
adverse outcomes such as increased morbidity [2], mortality [2,3]
and low grip strength [4]. Objective measures of physical capability,
the capacity to undertake the physical tasks of daily living, including
grip strength, have themselves been associated with morbidity [5]
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bone health may be informative to the maintenance of good levels
of physical capability in later life.
One of the most prominent minerals in bone is calcium [7] and it is
vital for bone health. Dietary calcium intake that reduces its deﬁcien-
cy may increase or maintain bone mass [8,9] and evidence suggests
that women in the lowest quintile of calcium intake have the highest
risk of ﬁrst fracture and osteoporosis [10]. Much of the 1% of calcium
that is not stored in the bones and teeth of adult humans is found in
the bloodstream and whilst serum calcium may not be an indicator
of calcium intake [11], its tight regulation is a driver of bone calcium
resorption [12], suggesting it may also be important to bone-related
outcomes. Lower levels of serum calcium have been associated with
increased risk of vertebral fractures [13], though there is so far little
evidence for associations with physical capability [14,15]. In addition
to factors such as immobility [16] and inactivity [17] being associated
with higher serum calcium in the elderly, there is also a genetic
component, with an estimated 33% heritability [18], and genome-
wide association studies (GWAS) have found that the T allele of SNP
rs1801725 (A986S) of the calcium-sensing receptor gene (CASR) is as-
sociated with increased serum calcium [19,20].
Bone mineral density (BMD) declines from mid-life, particularly
sharply in women after menopause [21]. BMD explains around 60% of
the variability of bone compression strength [22], is used in the diagno-
sis of osteoporosis [23] and is a predictor of fracture risk [24]. Common
sites for BMDmeasurement are the hip and lumbar spine, with moder-
ate correlation between the two [25]. Lower levels of BMD at these sites
have been associated with poorer measures of physical capability, in-
cluding grip strength and walking speed [4,26]. BMD and rates of
bone loss in later life may be modiﬁed by exercise programs [27], ciga-
rette smoking [28] and fat mass [29,30] in addition to having a substan-
tial genetic component, with heritability estimates of 77% and 89% for
hip and lumbar spine, respectively [31]. From GWAS, the G allele of
rs2941740, near ESR1, has been associated with increased hip and
lumbar spine BMD [32] and the C allele of rs9594759 near TNFSF11
(aka RANKL) has been associated with increased lumbar spine BMD
[32–34], along with some evidence for an association with hip BMD
[34].
Osteoarthritis (OA) is the most common joint disease and in addi-
tion to age and obesity [35], its risk may also be inﬂuenced by bone
quality [36]. OA at different sites has been associated with poorer
physical capability, such as slower 6 m walking speeds for hip OA
[37] and lower grip strength in individuals with hand OA [38]. Genetic
variants contributing to the estimated at least 40% heritability for
hand and knee OA [39] have been identiﬁed from GWAS, with the C
allele of SNP rs3815148 in COG5 associated with increased risk of
knee and/or hand OA [40].
We therefore hypothesised that SNPs associated with markers of
bone and joint health would be associated with levels of physical capa-
bility. To investigate this we analysed data from 12,836 participants
aged between 52 and 90+ years as part of the HALCyon (Healthy
Ageing across the Life Course; www.halcyon.ac.uk) collaborative re-
search programme in what we believe to be the largest investigation
into associations between these polymorphisms and physical capability.Methods
Study populations
The Medical Research Council National Survey of Health and
Development (NSHD) comprises participants sampled from all births
in a week in March 1946 and followed up since. In 1999, at age
53 years, men and women were visited by a research nurse and con-
sent for DNA extraction was given by approximately 2900 members
of the cohort. Details of the data collected and the several phases ofthe study are available on the cohort's website (www.nshd.mrc.ac.
uk) and elsewhere [41].
The English Longitudinal Study of Ageing (ELSA) comprisesmen and
women aged 50 years and over who originally participated in the
Health Survey for England in 1998, 1999 or 2001. Fieldwork began in
2002–03 (Phase I) with two-yearly follow-ups and in 2004–05 (Phase
II) blood samples were provided by 6231 participants. Details of
the cohort have been published [42].
The Hertfordshire Cohort Study (HCS) consists of 2997 participants
born 1931–39 and registered with a General Practitioner in East, North
or West Hertfordshire who attended a clinic in 1994–2004 (Phase I). A
second assessment took place in 2004–05 for participants in East
Hertfordshire (Phase II). Further details of study design, data collected
and summaries of participant characteristics have been published [43]
and are available on its website (www.mrc.soton.ac.uk/herts).
The Boyd Orr cohort is a historical cohort study based on children
surveyed in 1937–39 in English and Scottish districts. Participants
were followed-up for vital status via the NHSMedical Information Re-
search Service (MIRS) since 1948, with questionnaire administration
to survivors in 1997–98 (Phase II) and a research clinic visit in
2002–03 (Phase III), during which DNA was extracted from 728
adults, of which 385 had at least one physical capability measure
and one relevant genotype called for this analysis. Details of the
study design and the data collected have been described on its
website (www.epi.bris.ac.uk/boydorr) and elsewhere [44].
The Caerphilly Prospective Study (CaPS) recruited 2512 men aged
between45 and 59 years in 1979–83 from the town of Caerphilly, South
Wales, and its surrounding villages. Blood samples were collected at
baseline and at each of the four follow-ups (Phase II: 1984–88, Phase
III: 1989–93, Phase IV: 1993–97 and Phase V: 2002–04.) Further details
are available on the cohort's website (www.epi.bris.ac.uk/caerphilly/
caerphillyprospectivestudy.htm).
The Lothian Birth Cohort 1921 (LBC1921) participants were all
born in 1921 and most completed a cognitive ability assessment at
age 11 years. In 1999–2001 (Wave I), at approximately 79 years
old, 550 participants living in and around Edinburgh, underwent a se-
ries of cognitive and physical tests. Details of the recruitment into the
study are available on its website (www.lothianbirthcohort.ed.ac.uk)
and have been published previously [45,46].
Genotyping and quality control
Genotyping for SNPs rs1801725 (A986S, CASR), rs2941740 (ESR1),
rs9594759 (RANKL) and rs3815148 (COG5) was carried out by
KBioscience (www.kbioscience.co.uk) for the majority of studies. Ge-
notype information for rs1801725 in NSHD came from the Illumina
Metabochip (www.illumina.com). Genotype information for rs1801725
and rs2941740 (using proxy rs3020331) came from the Illumina
Human 610-Quadv1 Chip in LBC1921 [47]. Data quality was reviewed
by assessing clustering quality (using KBioscience software SNPviewer
on their data), call rates and deviation fromHardy–Weinberg equilibrium
(HWE).
Phenotypes
Anthropometry
Measurements were conducted either at clinics, during a clinical in-
terview in the home, or from self-report. Bodymass index (BMI kg/m2)
was calculated as weight (kg) divided by height (m) squared. Waist–hip
ratio (WHR) was deﬁned as waist circumference (cm) divided by hip
circumference (cm) and was measured in NSHD, ELSA, HCS, HAS, Boyd
Orr and CaPS.
Physical capability
Grip strength was measured in NSHD, ELSA, HCS and LBC1921
using electronic or hydraulic dynamometers, with the best measure
Table 1
Summary of sex, age and minor allele frequencies by cohort.
Cohort
Characteristic NSHD ELSA HCS Boyd Orr CaPS LBC1921 Total
Number of participants 2646 5612 2892 385 788 513 12836
Male, % 50 46 53 45 100 41 51
Agea in years, median (range) 53 65 (52–90+) 66 (59–73) 70 (64–82) 72 (65–83) 79 (77–80) 64 (52–90+)
Minor allele frequencies
CASR- rs1801725,T 0.13 0.13 0.13 0.14 0.11 0.14 0.13
ESR1- rs2941740, G 0.42 0.42 0.44 0.38 0.40 0.48 0.43
RANKL- rs9594759, C 0.44 0.45 0.45 0.44 0.45 0.43 0.45
COG5- rs3815148, C 0.23 0.23 0.23 0.19 0.22 0.25 0.23
Numbers of participants represent those with available data for at least one physical capability phenotype and at least one genotype.
aAge at phase from which the majority of variables are taken, i.e. Boyd Orr: III; CaPS: V; ELSA: II; HCS: I; LBC1921: I; NSHD: 1999 Collection; CaPS: Caerphilly Prospective Study;
ELSA: English Longitudinal Study of Ageing; HCS: Hertfordshire Cohort Study; LBC1921: Lothian Birth Cohort 1921; NSHD: National Survey of Health and Development.
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ing balance tests were conducted in the studies, with participants’
eyes open: ﬂamingo [48] (stopped at 30 s) in NSHD, HCS, Boyd Orr
and CaPS, and side-by-side, semi-tandem and full tandem [49] in
ELSA. Ability to balance was deﬁned in this analysis as the ability to
complete at least 5 s. The timed get up and go test [50] was carried
out in HCS, Boyd Orr and CaPS and required participants to get up
from a chair, walk 3 m, turn, walk back, turn and sit down. Timed
walks over 2.44 m (8 ft) and 6 m were carried out in ELSA and
LBC1921 respectively. Speeds were calculated for timed walks and
get up and go, with the fastest speeds used in the analysis where
more than one trial was conducted. Timed chair rises [51] involved
asking participants to rise from a chair and sit back down 5 times in
ELSA and HCS and 10 times in NSHD; the reciprocal of time taken inFig. 1.Meta-analyses for the associations between genotypes and grip strength. Adjusted fo
G/G; rs2941740 – per minor (G) allele; rs9594759 – per minor (C) allele; rs3815148 – (A/Cseconds×100 [52] was used in the analysis. Further details of these
measurements in these cohorts are presented elsewhere [53].
Demographic information
Demographic information was derived from self-reports. Where in-
formation on ethnicity was collected, participants of non-European an-
cestry were excluded from analyses to avoid confounding from
population stratiﬁcation [54]. Levels of physical activity were derived
from questionnaires in NSHD, ELSA, Boyd Orr, CaPS and LBC1921. Indi-
viduals were categorised as ‘physically active’ in this analysis if they en-
gaged, at least once a month, in at least moderate sport or activities
in NSHD, Boyd Orr, CaPS and LBC1921 or vigorous sport or activities
in ELSA. Participants’ alcohol consumption was dichotomised here
into ‘at least weekly’ and less often in all studies, except NSHD, wherer age and sex. Coefﬁcients based on z-scores. Models used: rs1801725 – (G/T+T/T) vs.
+C/C) vs. A/A.
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current smoking status and socio-economic position were also used.
Statistical methods
Within studies, linear and logistic regression analyses were
conducted on the continuous and dichotomous traitswithin the cohorts
respectively, adjusting for sex in all studies except CaPS, and age in all
studies except NSHD and LBC1921. Adjustments for anthropometric
and other demographic variables were made where appropriate. Due
to the low frequency of individuals homozygous for the T allele of
rs1801725 (n=207, 1.7%) and the C allele of rs3815148 (n=637,
5.1%), dominant models were used for these polymorphisms in order
to avoid the presentation of tables containing cells with very low fre-
quencies in particular cohorts. Additive models were used for
rs2941740 and rs9594759 with genotypes coded as 0, 1 and 2 for the
number of minor alleles. Likelihood ratio tests were used to compare
the ﬁt of the additive models compared with the full genotype model.
For continuous traits, the normality of the standardised residuals was
inspected with distributional diagnostic plots. For the harmonisation
of continuous traits thatwere used to obtain pooled estimates of the ge-
notypic effects, z-score units were calculated in each study by
subtracting the study mean and dividing by its standard deviation.
The overall mean for z-scores is 0 and standard deviation 1. Two-step
[55] meta-analyses using a random-effects model were performed to
obtain pooled genotypic effects. The I2 measure was used to quantify
heterogeneity [56]. Finally, the calculation of z-scores, for the continu-
ous traits, and the main analyses were repeated in males and females
separately. Reporting of the analyses met the appropriate items of
recommended checklists [57,58]. A two-tailed signiﬁcance level ofFig. 2.Meta-analyses for the associations between genotypes and timed get up and go/walk s
(G/T+T/T) vs. G/G; rs2941740 – per minor (G) allele; rs9594759 – per minor (C) allele; rs3815pb0.05was used as evidence of statistical signiﬁcance. Statistical analysis
was performed in Stata 11.2 (StataCorp LP).
Results
Cohort summaries and genotyping quality
A total of 12,836 adults aged between 52 and 90+ years had rel-
evant genotypic and phenotypic data available (Table 1). Summaries
of measures of body size and demographic characteristics are
presented in Table S1. The call rates were high, exceeding 93% across
all studies for the four polymorphisms. The HWE condition was met
in all studies for all polymorphisms (p>0.08), except for rs9594759
(RANKL) in NSHD (p=0.009) and CaPS (p=0.04).
Associations between genotypes and phenotypes
Associations between the genotypes and anthropometric and demo-
graphic variables are presented in Tables S2–S4, showing no evidence
for genotypic effects on any of the considered potential confounders for
physical capability in the pooled analyses, except for alcohol consumption
for rs9594759 (RANKL), with the C allele less common among frequent
drinkers (p=0.004, Fig. S1).
Figs. 1–4 and Tables S5–S8 show the associations between the poly-
morphisms and measures of physical capability adjusted for age and
sex. From the pooled analyses there was some evidence for an associa-
tion between the T allele of rs1801725 (CASR) and poorer grip strength
(p=0.05). There were no associations observed between any of the ge-
notypes and timed get up and go/walk speed (p>0.2). There was evi-
dence for an association between the C allele of rs9594759 and slowerpeed. Adjusted for age and sex. Coefﬁcients based on z-scores. Modelsused: rs1801725–
148 – (A/C+C/C) vs. A/A.
Fig. 3.Meta-analyses for the associations between genotypes and chair rises. Adjusted for age and sex. Coefﬁcients based on z-scores. Timed chair rises on reciprocal of time taken in
seconds×100. Models used: rs1801725 – (G/T+T/T) vs. G/G; rs2941740 – per minor (G) allele; rs9594759 – per minor (C) allele; rs3815148 – (A/C+C/C) vs. A/A.
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between the C allele of rs9594759 and poorer standing balance
(p=0.04), although this effect was only seen in females with some
evidence for a sex difference (p=0.05 for heterogeneity between males
and females, Fig. S2). There was evidence for heterogeneity between
males and females for the association between rs3815148 (COG5) and
standing balance, (p=0.012, Fig. S3) with the observed effects in oppo-
site directions. No other genotypic associations with physical capability
measures or evidence for sex differences were observed.
Additional adjustment for alcohol consumption for the genotypic
effects of rs9594759 did not substantially affect its associations with
chair rises (pooled beta for z-score=−0.031, 95% CI: −0.060 to −
0.002, p=0.04, n=8184) and standing balance in females (pooled
OR=0.85, 95% CI: 0.75–0.96, p=0.01, data not shown).
In only a relatively small number of tests did the full genotypemodel
represent a signiﬁcantly better ﬁt than the per allele model: rs9594759
for weight and BMI in Boyd Orr, smoking status and timed walk in
LBC1921; rs2941740 for smoking status in ELSA, socio-economic posi-
tion in NSHD and balance in CaPS.
Discussion
In this large, multi-cohort study of older adults we investigated as-
sociations between robust genetic markers of serum calcium, bone
mineral density and osteoarthritis risk andmeasures of physical capa-
bility in six UK cohorts of 12,836 adults aged between 52 and 90+
years. We found marginal evidence for an association between
rs1801725 (CASR) and grip strength, with carriers of the allele associ-
ated with raised serum calcium levels, identiﬁed from GWAS [19,20],
having lower grip strength. However, the effect sizewas small at−0.03
z-score units for carriers of the T allele, adjusting for age and sex,
representing 0.33 kg assuming a standard deviation of 11. We alsofound some evidence for the association of the BMD-raising allele (C)
of rs9594759 (RANKL) [32–34] with slower chair rise times and poorer
standing balance. This direction was unexpected; however, the inter-
pretation of these results should be treated with caution as the HWE
condition was not met for rs9594759 (RANKL) in NSHD and CaPS, and
whilst exclusion of the studies is not recommended [59], both studies
contributed to the meta-analysis for standing balance and NSHD also
contributed to that for chair rises. There were no observed associations
with the physical capability measures for the BMD-raising allele of
rs2941740 (ESR1). To the best of our knowledge, this is the ﬁrst report
of an investigation between a polymorphism in the COG5 region and
physical capability and we found no evidence that carriers of the risk al-
lele for osteoarthritis of rs3815148 had poorer physical capability mea-
sures in the combined analyses of men and women. Due to the sex
differences in bone loss rate in later life [21], we additionally investigated
genotypic effects separately inmen andwomen;we found borderline ev-
idence for a difference in the effects of rs9594759 (RANKL) on standing
balance by sex, with the effects only observed in women, and opposing
directions of effect for rs3815148 (COG5) on standing balance, though
we found no evidence for other differences.
Genetic variants are generally not associated with typical con-
founders in observational epidemiology and, being ﬁxed from concep-
tion, may be informative about the direction of causality [60]. We
found no evidence of association between rs1801725 (CASR) and mea-
sures of anthropometry, physical activity levels or other demographic
indicators. Additionally, previous investigations of CASR polymor-
phisms have found evidence against associations with many traits in-
cluding, vitamin D levels [61], osteoarthritis [19], osteoporosis [19] or
hip BMD [19,20], as well as no[19] or only modest [20] associations
with lumbar spine BMD; however, there is some evidence that
their effects on BMDmay bemodiﬁed by birth-weight [62]. Although
a previous smaller study of 1252 females aged between 70 and
Fig. 4. Meta-analyses for the associations between genotypes and ability to balance for at least 5 s. Adjusted for age and sex. Models used: rs1801725 – (G/T+T/T) vs. G/G;
rs2941740 – per minor (G) allele; rs9594759 – per minor (C) allele; rs3815148 – (A/C+C/C) vs. A/A.
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strength or timed up and go [17], our ﬁndings based on a larger num-
ber of individuals (n=11,239) suggest that our observed association
between rs1801725 and grip strength may indicate a causal role of
raised serum calcium levels on poorer grip strength. The association
observed with grip strength but not with the three other physical ca-
pability phenotypes may be indicative of greater power due to the
larger number of participants with available data with this trait.
The inconsistent ﬁndings for the direction of effects for the BMD-
raising alleles of the two SNPs considered and the associations observed
for rs9594759 (RANKL) suggest further investigations are warranted in
order to provide additional evidence for or against the causal role of
BMD on physical capability. Previous smaller studies of older females
(n=421 [63] and 331 [64]) found no association between measures
of physical performance, including grip strength, and SNP rs2234693,
a variant in low LD (r2=0.04) with rs2941740 (ESR1).
Our investigationwas limited by the fact thatwe did not validate the
genotypic effects of the SNPs on serumcalcium, BMDor osteoarthritis in
these studies. However, all of the SNPs chosen were robustly associated
with their respectivemeasures from large GWAS of individuals of Euro-
pean ancestry. The use of younger populations may help to elucidate
whether associations are present at earlier stages of the life course.
Our survey of the literature for SNP selection for this study was
conducted prior to the emergence of evidence for further genotypic as-
sociations with BMD [65] and OA [66] and, therefore, additional insight
could be gained from other large investigations using new loci for asso-
ciations with these traits.It is clear that adequate calcium intake is essential for bone health
[8,9] as well as having other beneﬁts, including possibly protecting
against obesity [67]. However, calcium intake above the level required
by bones is likely to be excreted through the urine [7] and there is
even evidence that higher levels of calcium intake (greater than around
1100 mg) may increase the risk of hip fractures [10]. Higher levels of
serum calcium may have other adverse consequences including in-
creased cardiovascular andmortality risk [68]. Hypocalcaemia is also as-
sociatedwithmuscleweakness and fatigue and a small study of patients
with primary hyperparathyroidism found the post-surgical reduction in
serum calciumwas correlatedwith improved strength [69]. Our use of a
genetic variant of serum calcium provides additional insight into the ef-
fects of long-term raised serum calcium levels on measures of physical
capability. As a result, greatly exceeding the UK recommendation of
700 mg calcium per day for adults [70] is not advised, and a preference
for food sources over pharmacological supplementsmay lead to smaller
effects on serum levels [68,71]. Whilst further studies are needed to
infer causality between BMD and physical capability, attention should
still be paid to themodiﬁable factors of bonemass, such as exercise pro-
grams [27], that would be beneﬁcial to osteoporosis risk [23,24] as well
as to the maintenance of good physical capability.
Conclusion
The results of this large multi-cohort study of older adults suggest
elevated serum calcium levels may lead to lower grip strength but
provide no evidence for its effect on other measures of physical
284 T. Alfred et al. / Bone 52 (2013) 278–285capability. Genetic markers of BMD and osteoarthritis risk provided
null or inconsistent associations with measures of physical capability.Acknowledgments
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